Fructose Science

2025-2026 Evidence Update

Summary: Recent literature strengthens the central Fructose Science framework: fructose is not only a calorie source, but a substrate that can affect intestinal absorption, portal delivery, hepatic ATP stress, uric acid production, de novo lipogenesis, gut barrier signaling, and inflammatory pathways.

A 2025 review by Li, Fan, Gao, Pan, Ma, Cheng, and colleagues in Molecular Biomedicine summarizes fructose metabolism across metabolic disease, inflammation, and cancer, including MASLD, hyperinsulinemia, hyperuricemia, gut inflammation, liver inflammation, neuroinflammation, and context-dependent tumor metabolism. The review is useful because it connects the classic liver pathway with immune and inflammatory biology.

The gut-liver axis also deserves more emphasis. Jung and colleagues reported in Nature Metabolism that a dietary-fiber-adapted gut microbiome can clear dietary fructose and reverse hepatic steatosis in an experimental model, while Westerbeke and colleagues reviewed fructose catabolism through host-microbiota interactions and ethnic variation. These studies support a practical point repeated across this section: food structure, fiber, microbiome capacity, and dose matter.

Sources: Li Z. et al., PMID 40549205; Jung S. et al., PMID 40954286; Westerbeke F.H.M. et al., PMID 39805044.

Mechanisms and pathways: fructose metabolism, the liver, uric acid, hormones, insulin resistance, triglycerides, cellular energy stress, and disease biology.